Cited by 1,197Nicotinic Acetylcholine Receptors StudyNeuroscience and Neuropharmacology ResearchSmoking Behavior and Cessation

Nicotinic Acetylcholine Receptors and Nicotinic Cholinergic Mechanisms of the Central Nervous System

Dani, John A., Bertrand, Daniel·2007·Annual Review of Pharmacology and Toxicology

Abstract

Subtypes of neuronal nicotinic acetylcholine receptors (nAChRs) are constructed from numerous subunit combinations that compose channel-receptor complexes with varied functional and pharmacological characteristics. Structural and functional diversity and the broad presynaptic, postsynaptic, and nonsynaptic locations of nAChRs underlie their mainly modulatory roles throughout the mammalian brain. Presynaptic and preterminal nicotinic receptors enhance neurotransmitter release, postsynaptic nAChRs contribute a small minority of fast excitatory transmission, and nonsynaptic nAChRs modulate many neurotransmitter systems by influencing neuronal excitability. Nicotinic receptors have roles in development and synaptic plasticity, and nicotinic mechanisms participate in learning, memory, and attention. Decline, disruption, or alterations of nicotinic cholinergic mechanisms contribute to dysfunctions such as epilepsy, schizophrenia, Parkinson's disease, autism, dementia with Lewy bodies, Alzheimer's disease, and addiction.

Integrity signals

Registry

Crossref · 10.1146/annurev.pharmtox.47.120505.105214

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • One of the first and most common cellular adaptations after chronic nicotine exposure is up-regulation of nicotinic receptor levels.

    “One of the first and most common cellular adaptations following chronic nicotine exposure is the up-regulation of nicotinic receptor levels (Dani and Bertrand 2007).”
  • The most abundant neuronal nAChR subtype is the α4β2 nAChR, which has high affinity for nicotine.

    “The most abundant neuronal subtype is the α4β2 nAChR, which has high affinity for nicotine (Dani & Bertrand, 2007).”

    From <scp>N</scp> icotine and the adolescent brain (2015) · cites this paper as Dani & Bertrand, 2007

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Dani, J. A., & Bertrand, D.
Affiliations
  • Baylor College of Medicine (US)
  • Department of Neuroscience, Centre Médical Universitaire, Geneva, Switzerland;
Venue
Annual Review of Pharmacology and Toxicology
Published
2007-02-01
Volume
47
Issue
1
Pages
699-729
ISSN
  • 0362-1642 (ISSN-L)
  • 1545-4304
OpenAlex
W2170194206
Cited by
1,197
References
14
Citations by year
2026: 29 · 2025: 42 · 2024: 32 · 2023: 38 · 2022: 42 · 2021: 60 · 2020: 61 · 2019: 49 · 2018: 60 · 2017: 47 · 2016: 89 · 2015: 81 · 2014: 87 · 2013: 77 · 2012: 70
FWCI
5.01
Type
journal article
Language
en
Open access
closed
Locations
  • The Annual Review of Pharmacology and Toxicology (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health
  • National Institute on Drug Abuse
  • National Institute of Neurological Disorders and Stroke (R01NS021229)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
  • Health Sciences › Medicine › Physiology › Smoking Behavior and Cessation
Keywords
nicotinic acetylcholine receptors, central nervous system, receptor subunit composition, presynaptic nicotinic receptors, neurotransmitter release, synaptic plasticity, learning and memory, attention, neuropsychiatric disorders, epilepsy, schizophrenia, Parkinson's disease, autism spectrum disorder, dementia with Lewy bodies, Alzheimer's disease, addiction
MeSH terms
Alzheimer Disease, Animals, Brain, Epilepsy, Humans, Memory, Receptors, Nicotinic, Neurotransmitter Agents, Substance-Related Disorders

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review